Anti-EGFR monoclonal antibody-DM1 conjugate
Alternative Names: Anti-EGFR DM1Latest Information Update: 14 Feb 2024
At a glance
- Originator ImmunoGen
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Macrolides; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants; Epidermal growth factor inhibitors; Mitosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 12 Feb 2024 ImmunoGen has been acquired by AbbVie
- 25 Nov 1998 Suspended-Preclinical for Cancer in USA (Parenteral)
- 29 May 1995 Preclinical development for Cancer in USA (Parenteral)